New Zealand markets closed

ImmunoPrecise Antibodies Ltd. (IPA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.8500-0.1500 (-3.00%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
30/04/2022
30/04/2021
30/04/2020
30/04/2019
Total revenue
19,465
19,364
17,912
14,058
10,926
Cost of revenue
8,509
8,381
6,374
6,024
5,632
Gross profit
10,956
10,983
11,538
8,034
5,295
Operating expenses
Research development
11,352
6,693
1,974
446.28
485.845
Selling general and administrative
18,904
17,710
13,339
8,328
8,469
Total operating expenses
33,496
27,153
15,714
12,081
11,520
Operating income or loss
-22,540
-16,170
-4,176
-4,047
-6,225
Interest expense
366
419
863
1,436
1,319
Total other income/expenses net
41
462
-1,238
-82.316
-99.216
Income before tax
-22,590
-15,848
-5,995
-5,293
-7,613
Income tax expense
270
861
1,345
-345.728
4.788
Income from continuing operations
-22,860
-16,709
-7,340
-4,947
-7,617
Net income
-22,860
-16,709
-7,340
-4,947
-7,617
Net income available to common shareholders
-22,860
-16,709
-7,340
-4,947
-7,617
Basic EPS
-
-0.85
-0.45
-0.35
-0.60
Diluted EPS
-
-0.85
-0.45
-0.35
-0.60
Basic average shares
-
19,688
16,474
13,629
12,542
Diluted average shares
-
19,688
16,474
13,629
12,542
EBITDA
-
-11,660
-1,419
-448.577
-4,031